Publications

09 October 2003 /Prices and reimbursement

Note on products for Alzheimer's disease in Denmark

This study sheds light on the development of the use of medicinal products for Alzheimer's disease during the period September 1997 until April 2003. Four medicinal products are used for treating Alzheimer's disease - 3 cholinesterase inhibitors (Aricept®, Exelon® and Reminyl®) and a glutamine

30 September 2003 /Prices and reimbursement

The sale of the anti-cholinergic agent Spiriva®

Since Spiriva® was introduced on the market in the second quarter of 2002, there has been a great increase in both the consumption and prevalence of the agent among the elderly.

22 May 2003 /Prices and reimbursement

Investigation of pharmacies' dispense practice

The purpose of the present investigation is to shed light on the variations in pharmaceutical companies' market shares at individual pharmacies and to investigate whether these differences mean that the dispense practice is inappropriate or expensive.

01 April 2003 /Prices and reimbursement

Hoarding of medicinal products in the need-dependent reimbursement system

This analysis indicates that hoarding is a problem within the need-dependent reimbursement system. Among medicine users with expenses exceeding DKK 510 within a reimbursement year, hoarding is estimated to constitute approximately 2 per cent of the users' reimbursable medicine expenses.